0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BCG Vaccine for Intradermal Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18S13329
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global BCG Vaccine for Intradermal Injection Market Research Report 2023
BUY CHAPTERS

Global BCG Vaccine for Intradermal Injection Market Research Report 2025

Code: QYRE-Auto-18S13329
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

BCG Vaccine for Intradermal Injection Market

The global market for BCG Vaccine for Intradermal Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for BCG Vaccine for Intradermal Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for BCG Vaccine for Intradermal Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of BCG Vaccine for Intradermal Injection include Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, Intervax, GSBPL, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for BCG Vaccine for Intradermal Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine for Intradermal Injection.
The BCG Vaccine for Intradermal Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BCG Vaccine for Intradermal Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Vaccine for Intradermal Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of BCG Vaccine for Intradermal Injection Market Report

Report Metric Details
Report Name BCG Vaccine for Intradermal Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, Intervax, GSBPL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of BCG Vaccine for Intradermal Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of BCG Vaccine for Intradermal Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the BCG Vaccine for Intradermal Injection Market report?

Ans: The main players in the BCG Vaccine for Intradermal Injection Market are Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, Intervax, GSBPL

What are the Application segmentation covered in the BCG Vaccine for Intradermal Injection Market report?

Ans: The Applications covered in the BCG Vaccine for Intradermal Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the BCG Vaccine for Intradermal Injection Market report?

Ans: The Types covered in the BCG Vaccine for Intradermal Injection Market report are BCG for Immunization, BCG for Therapy

Recommended Reports

BCG & Tuberculosis

Immunization Vaccines

Injection & Delivery

1 BCG Vaccine for Intradermal Injection Market Overview
1.1 Product Definition
1.2 BCG Vaccine for Intradermal Injection by Type
1.2.1 Global BCG Vaccine for Intradermal Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 BCG for Immunization
1.2.3 BCG for Therapy
1.3 BCG Vaccine for Intradermal Injection by Application
1.3.1 Global BCG Vaccine for Intradermal Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global BCG Vaccine for Intradermal Injection Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine for Intradermal Injection Revenue 2020-2031
1.4.2 Global BCG Vaccine for Intradermal Injection Sales 2020-2031
1.4.3 Global BCG Vaccine for Intradermal Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 BCG Vaccine for Intradermal Injection Market Competition by Manufacturers
2.1 Global BCG Vaccine for Intradermal Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global BCG Vaccine for Intradermal Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of BCG Vaccine for Intradermal Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Product Type & Application
2.7 Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Date of Enter into This Industry
2.8 Global BCG Vaccine for Intradermal Injection Market Competitive Situation and Trends
2.8.1 Global BCG Vaccine for Intradermal Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest BCG Vaccine for Intradermal Injection Players Market Share by Revenue
2.8.3 Global BCG Vaccine for Intradermal Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global BCG Vaccine for Intradermal Injection Market Scenario by Region
3.1 Global BCG Vaccine for Intradermal Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global BCG Vaccine for Intradermal Injection Sales by Region: 2020-2031
3.2.1 Global BCG Vaccine for Intradermal Injection Sales by Region: 2020-2025
3.2.2 Global BCG Vaccine for Intradermal Injection Sales by Region: 2026-2031
3.3 Global BCG Vaccine for Intradermal Injection Revenue by Region: 2020-2031
3.3.1 Global BCG Vaccine for Intradermal Injection Revenue by Region: 2020-2025
3.3.2 Global BCG Vaccine for Intradermal Injection Revenue by Region: 2026-2031
3.4 North America BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.4.1 North America BCG Vaccine for Intradermal Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America BCG Vaccine for Intradermal Injection Sales by Country (2020-2031)
3.4.3 North America BCG Vaccine for Intradermal Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.5.1 Europe BCG Vaccine for Intradermal Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe BCG Vaccine for Intradermal Injection Sales by Country (2020-2031)
3.5.3 Europe BCG Vaccine for Intradermal Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Vaccine for Intradermal Injection Market Facts & Figures by Region
3.6.1 Asia Pacific BCG Vaccine for Intradermal Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific BCG Vaccine for Intradermal Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.7.1 Latin America BCG Vaccine for Intradermal Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America BCG Vaccine for Intradermal Injection Sales by Country (2020-2031)
3.7.3 Latin America BCG Vaccine for Intradermal Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Vaccine for Intradermal Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Vaccine for Intradermal Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa BCG Vaccine for Intradermal Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BCG Vaccine for Intradermal Injection Sales by Type (2020-2031)
4.1.1 Global BCG Vaccine for Intradermal Injection Sales by Type (2020-2025)
4.1.2 Global BCG Vaccine for Intradermal Injection Sales by Type (2026-2031)
4.1.3 Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2020-2031)
4.2 Global BCG Vaccine for Intradermal Injection Revenue by Type (2020-2031)
4.2.1 Global BCG Vaccine for Intradermal Injection Revenue by Type (2020-2025)
4.2.2 Global BCG Vaccine for Intradermal Injection Revenue by Type (2026-2031)
4.2.3 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2020-2031)
4.3 Global BCG Vaccine for Intradermal Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global BCG Vaccine for Intradermal Injection Sales by Application (2020-2031)
5.1.1 Global BCG Vaccine for Intradermal Injection Sales by Application (2020-2025)
5.1.2 Global BCG Vaccine for Intradermal Injection Sales by Application (2026-2031)
5.1.3 Global BCG Vaccine for Intradermal Injection Sales Market Share by Application (2020-2031)
5.2 Global BCG Vaccine for Intradermal Injection Revenue by Application (2020-2031)
5.2.1 Global BCG Vaccine for Intradermal Injection Revenue by Application (2020-2025)
5.2.2 Global BCG Vaccine for Intradermal Injection Revenue by Application (2026-2031)
5.2.3 Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2020-2031)
5.3 Global BCG Vaccine for Intradermal Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck BCG Vaccine for Intradermal Injection Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Company Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Pasteur BCG Vaccine for Intradermal Injection Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Company Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Japan BCG Lab BCG Vaccine for Intradermal Injection Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 Shanghai Institute of Biological Products
6.4.1 Shanghai Institute of Biological Products Company Information
6.4.2 Shanghai Institute of Biological Products Description and Business Overview
6.4.3 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product Portfolio
6.4.5 Shanghai Institute of Biological Products Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India BCG Vaccine for Intradermal Injection Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Company Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Intervax BCG Vaccine for Intradermal Injection Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.7.1 GSBPL Company Information
6.7.2 GSBPL Description and Business Overview
6.7.3 GSBPL BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GSBPL BCG Vaccine for Intradermal Injection Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Vaccine for Intradermal Injection Industry Chain Analysis
7.2 BCG Vaccine for Intradermal Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Vaccine for Intradermal Injection Production Mode & Process Analysis
7.4 BCG Vaccine for Intradermal Injection Sales and Marketing
7.4.1 BCG Vaccine for Intradermal Injection Sales Channels
7.4.2 BCG Vaccine for Intradermal Injection Distributors
7.5 BCG Vaccine for Intradermal Injection Customer Analysis
8 BCG Vaccine for Intradermal Injection Market Dynamics
8.1 BCG Vaccine for Intradermal Injection Industry Trends
8.2 BCG Vaccine for Intradermal Injection Market Drivers
8.3 BCG Vaccine for Intradermal Injection Market Challenges
8.4 BCG Vaccine for Intradermal Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global BCG Vaccine for Intradermal Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global BCG Vaccine for Intradermal Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global BCG Vaccine for Intradermal Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global BCG Vaccine for Intradermal Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global BCG Vaccine for Intradermal Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global BCG Vaccine for Intradermal Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market BCG Vaccine for Intradermal Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of BCG Vaccine for Intradermal Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Product Type & Application
 Table 12. Global Key Manufacturers of BCG Vaccine for Intradermal Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global BCG Vaccine for Intradermal Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BCG Vaccine for Intradermal Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global BCG Vaccine for Intradermal Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global BCG Vaccine for Intradermal Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global BCG Vaccine for Intradermal Injection Sales Market Share by Region (2020-2025)
 Table 19. Global BCG Vaccine for Intradermal Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global BCG Vaccine for Intradermal Injection Sales Market Share by Region (2026-2031)
 Table 21. Global BCG Vaccine for Intradermal Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global BCG Vaccine for Intradermal Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America BCG Vaccine for Intradermal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America BCG Vaccine for Intradermal Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America BCG Vaccine for Intradermal Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America BCG Vaccine for Intradermal Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America BCG Vaccine for Intradermal Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe BCG Vaccine for Intradermal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe BCG Vaccine for Intradermal Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe BCG Vaccine for Intradermal Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe BCG Vaccine for Intradermal Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe BCG Vaccine for Intradermal Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific BCG Vaccine for Intradermal Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific BCG Vaccine for Intradermal Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific BCG Vaccine for Intradermal Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America BCG Vaccine for Intradermal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America BCG Vaccine for Intradermal Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America BCG Vaccine for Intradermal Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa BCG Vaccine for Intradermal Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa BCG Vaccine for Intradermal Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa BCG Vaccine for Intradermal Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2020-2025)
 Table 53. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type (2026-2031)
 Table 54. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global BCG Vaccine for Intradermal Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global BCG Vaccine for Intradermal Injection Sales Market Share by Application (2020-2025)
 Table 63. Global BCG Vaccine for Intradermal Injection Sales Market Share by Application (2026-2031)
 Table 64. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global BCG Vaccine for Intradermal Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global BCG Vaccine for Intradermal Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck BCG Vaccine for Intradermal Injection Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Sanofi Pasteur Company Information
 Table 76. Sanofi Pasteur Description and Business Overview
 Table 77. Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Pasteur BCG Vaccine for Intradermal Injection Product
 Table 79. Sanofi Pasteur Recent Developments/Updates
 Table 80. Japan BCG Lab Company Information
 Table 81. Japan BCG Lab Description and Business Overview
 Table 82. Japan BCG Lab BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Japan BCG Lab BCG Vaccine for Intradermal Injection Product
 Table 84. Japan BCG Lab Recent Developments/Updates
 Table 85. Shanghai Institute of Biological Products Company Information
 Table 86. Shanghai Institute of Biological Products Description and Business Overview
 Table 87. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product
 Table 89. Shanghai Institute of Biological Products Recent Developments/Updates
 Table 90. Serum Institute of India Company Information
 Table 91. Serum Institute of India Description and Business Overview
 Table 92. Serum Institute of India BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Serum Institute of India BCG Vaccine for Intradermal Injection Product
 Table 94. Serum Institute of India Recent Developments/Updates
 Table 95. Intervax Company Information
 Table 96. Intervax Description and Business Overview
 Table 97. Intervax BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Intervax BCG Vaccine for Intradermal Injection Product
 Table 99. Intervax Recent Developments/Updates
 Table 100. GSBPL Company Information
 Table 101. GSBPL Description and Business Overview
 Table 102. GSBPL BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GSBPL BCG Vaccine for Intradermal Injection Product
 Table 104. GSBPL Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. BCG Vaccine for Intradermal Injection Distributors List
 Table 108. BCG Vaccine for Intradermal Injection Customers List
 Table 109. BCG Vaccine for Intradermal Injection Market Trends
 Table 110. BCG Vaccine for Intradermal Injection Market Drivers
 Table 111. BCG Vaccine for Intradermal Injection Market Challenges
 Table 112. BCG Vaccine for Intradermal Injection Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of BCG Vaccine for Intradermal Injection
 Figure 2. Global BCG Vaccine for Intradermal Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global BCG Vaccine for Intradermal Injection Market Share by Type: 2024 & 2031
 Figure 4. BCG for Immunization Product Picture
 Figure 5. BCG for Therapy Product Picture
 Figure 6. Global BCG Vaccine for Intradermal Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global BCG Vaccine for Intradermal Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global BCG Vaccine for Intradermal Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global BCG Vaccine for Intradermal Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global BCG Vaccine for Intradermal Injection Sales (2020-2031) & (K Units)
 Figure 14. Global BCG Vaccine for Intradermal Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. BCG Vaccine for Intradermal Injection Report Years Considered
 Figure 16. BCG Vaccine for Intradermal Injection Sales Share by Manufacturers in 2024
 Figure 17. Global BCG Vaccine for Intradermal Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest BCG Vaccine for Intradermal Injection Players: Market Share by Revenue in BCG Vaccine for Intradermal Injection in 2024
 Figure 19. BCG Vaccine for Intradermal Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global BCG Vaccine for Intradermal Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America BCG Vaccine for Intradermal Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe BCG Vaccine for Intradermal Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific BCG Vaccine for Intradermal Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific BCG Vaccine for Intradermal Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America BCG Vaccine for Intradermal Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa BCG Vaccine for Intradermal Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE BCG Vaccine for Intradermal Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of BCG Vaccine for Intradermal Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of BCG Vaccine for Intradermal Injection by Type (2020-2031)
 Figure 53. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of BCG Vaccine for Intradermal Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of BCG Vaccine for Intradermal Injection by Application (2020-2031)
 Figure 56. Global BCG Vaccine for Intradermal Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. BCG Vaccine for Intradermal Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network